Navigation Links
New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma

nium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. Millennium's website is www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and development of products. Various important risks may cause the Company's actual results to differ materially from the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. T
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
5. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
8. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
9. Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered Cured
10. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
11. Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies
Post Your Comments:
(Date:7/25/2014)... HILL, N.C. , July 25, 2014  In ... area is costly and challenging - as is managing ... Is it possible - or even ... together? If so, where can you combine resources and ... separated? These are just a few ...
(Date:7/25/2014)... , July 25, 2014  Depomed, Inc. (NASDAQ: ... release second quarter fiscal year 2014 financial results after ... will host a conference call beginning at 4:30 pm ... can access the call by dialing 877-317-6789 ( ... call will also be available via a live webcast ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- ScriptPro, of Mission, Kansas ... Lake, Wisconsin , announce that they will ... agreement allowing ScriptPro to bring TCGRx adherence packaging ... United States . ScriptPro is a leading ... to retail and ambulatory pharmacies. TCGRx distributes and ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3
... WASHINGTON, Sept. 1, 2011 The Pharmacy Technician Certification ... announced today that Melissa Murer Corrigan, PTCB Executive Director ... November 2011 to join ACT,s Workforce Development Division as ... a search for a new executive in the coming ...
... 2011 Cardium Therapeutics (NYSE Amex: CXM ) ... Officer, will present at the Rodman & Renshaw Annual Healthcare ... Eastern Time.  The conference is being held September 11-13 at ... the Company,s presentation will be available live and by replay ...
Cached Medicine Technology:PTCB Board of Governors Announces Executive Director/CEO Murer Corrigan to Leave Organization 2Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference 2
(Date:7/28/2014)... Community Health Center of Snohomish County ... pharmacy services, has released an article designed to educate ... . Founded in 1983, the health center has a ... county that face barriers to obtaining high quality yet ... at the CHC, click here: http://www.chcsno.org/locations.ashx?p=1099 , ...
(Date:7/28/2014)... According to court documents, the conflict dates ... The Marcal Group (TMG), met with Rafael H. Harel, ... as well a broad project outline, were agreed upon for ... branding services and marketing. , Though Caller continued ... the course of the project, praise was not accompanied by ...
(Date:7/28/2014)... IL (PRWEB) July 28, 2014 ... for mental health professionals, announced today its affiliation with ... (IAMFT). This new relationship allows TherapySites to continue ... adding exclusive benefits and promotional offers. , “There has ... being done today. With nearly 3 billion Internet ...
(Date:7/28/2014)... Wa (PRWEB) July 28, 2014 According to ... this is a comprehensive guide that will help people get ... to readers all the necessary information about heartburn and acid ... the truth about heartburn , and risk factors for reflux ... book will help people get rid of symptoms of reflux ...
(Date:7/28/2014)... July 28, 2014 Shore Points Capital ... its investment in Loftware, Inc., through a recapitalization of ... Points was the lead investor in Loftware for over ... become the leading international provider of enterprise level software ... been a great investment for us, and we are ...
Breaking Medicine News(10 mins):Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3Health News:Calko Medical Center Loses Website Twice over Non-Payment, According to Court Documents 2Health News:TherapySites (Websites for Therapists) Partners with the Illinois Association for Marriage and Family Therapy 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 2Health News:Heartburn No More Pdf Review Exposes Jeff Martin's Guide For Treating Heartburn – Vkool.com 3Health News:Shore Points Capital Announces Sale of Portfolio Company Loftware 2
... , WASHINGTON , Jan. 12 ... District Court in Miami to participating in a conspiracy to ... of the Criminal Division; U.S. Attorney Terrence I. Berg ... , Special Agent-in-Charge of the FBI,s Detroit Field Office; and Daniel ...
... amount of amyloid plaques affected olfactory sense, , TUESDAY, Jan. ... loss of smell could serve as an early indicator of ... suffer from loss of smell. But the new research pinpoints ... bits of gunk in the brain that cause Alzheimer,s disease ...
... Jan. 12 The U.S. Agency for International Development ... as mission director to South Africa .  Senior Deputy Assistant ... the oath to Borns. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , As ... a program exceeding $500 million this fiscal year.  Borns ...
... , ATLANTA , Jan. 12 ... tapped its national animal rescue network to provide financial and logistical ... was destroyed by fire yesterday. The caregiver for the dogs, ... Door Rescuer" and nationally recognized for her passionate efforts to caring ...
... group target use of cell phones and texting devices, ... 500,000 people were injured and nearly 6,000 people were ... who was distracted while using a cell phone or ... , To cut down on the growing number of ...
... , CHICAGO , Jan. 12 ... bankrupt Mid-States Express Inc. of Aurora, Ill. , for ... beneficiaries in the company,s 401(k) and health plans.  The department,s ... to employees that their medical bills were not likely to be paid, even ...
Cached Medicine News:Health News:Clinic Manager Pleads Guilty in Medicare Fraud Scheme 2Health News:Clinic Manager Pleads Guilty in Medicare Fraud Scheme 3Health News:New USAID Mission Director for South Africa Sworn In 2Health News:American Dog Rescue Provides Aid to Displaced Dogs Following House Fire of Atlanta's 'Dog Next Door' Animal Rescuer 2Health News:FocusDriven Seeks to Crack Down on Distracted Drivers 2Health News:U.S. Labor Department sues owners of bankrupt Aurora, Ill., trucking company to recover $3 million in unpaid employee medical claims 2Health News:U.S. Labor Department sues owners of bankrupt Aurora, Ill., trucking company to recover $3 million in unpaid employee medical claims 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: